Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Clearside Biomedical, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$8.91 - $14.54 $400,950 - $654,300	-45,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $250,650 - $642,600	45,000 New	45,000 $483,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

12.2M

Call Options Held

54.7K

Put Options Held

50.7K

Vanguard Group Inc Valley Forge, PA

2.84M
Shares

$2.47 Million
0.0% of portfolio
Act Capital Management, LLC Wayne, PA

2.2M
Shares

$1.91 Million
3.43% of portfolio
Carmignac Gestion Paris, I0

1.93M
Shares

$1.68 Million
0.04% of portfolio
Black Rock Inc. New York, NY

798K
Shares

$694,379
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

745K
Shares

$648,053
0.0% of portfolio

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account